Clinical Trial Update: 3°C Saline Injection at the Duodenal Papilla to Prevent Post-ERCP Pancreatitis [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial evaluating whether injecting cold saline (3°C) at the duodenal papilla can prevent post-ERCP pancreatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Normal saline (0.9% NaCl) injection (sodium chloride solution)

Snippet

Sponsor: Universidad Nacional de Colombia | Conditions: Pancreatitis | Phase 2, Phase 3 | Status: COMPLETED